Jeena Sikho Lifecare Limited
All news and filings related to Jeena Sikho Lifecare Limited.
View all news & filings- Medium impact
Jeena Sikho Lifecare's Pune Hospital Receives NABH Accreditation
Jeena Sikho Lifecare Limited's Pune Hospital has received NABH accreditation for its Panchakarma services. The accreditation is valid until July 27, 2029. This signifies adherence to quality healthcare standards.
Read the summary - Low impact
Jeena Sikho Lifecare Launches Two New Ayurvedic Products
Jeena Sikho Lifecare Limited launched two new Ayurvedic products: Acharya Ji's Jeevanodya Vati and Acharya Ji's Ojavardhan Vati, both in 60-tablet packs. The launch occurred on September 5, 2026, and aims to expand the company's wellness product portfolio.
Read the summary - Low impact
Jeena Sikho Lifecare Announces 9th AGM and E-Voting Details
Jeena Sikho Lifecare Limited announced its 9th Annual General Meeting (AGM) and provided e-voting information. Advertisements were published on September 5, 2026, in Financial Express and Nawanzamana. Details will be available on the company's website.
Read the summary - Low impact
Jeena Sikho Lifecare Dispatches Annual Report & AGM Notice for FY26
Jeena Sikho Lifecare Limited will hold its 9th AGM on September 28, 2026. The company has dispatched the Integrated Annual Report for FY26 and AGM notice to shareholders. Shareholders in physical mode are reminded to update KYC details by April 1, 2024, to ensure payment eligibility.
Read the summary - Medium impact
Jeena Sikho Lifecare Announces 9th AGM on Sep 28, 2026, Releases FY26 Annual Report
Jeena Sikho Lifecare will hold its 9th AGM on September 28, 2026. The company released its FY26 Integrated Annual Report, proposing a final dividend of ₹4.50 per equity share. Key agenda items include adopting FY26 financial statements and reappointing/appointing directors.
Read the summary - Medium impact
Jeena Sikho Lifecare Announces 9th AGM on Sep 28, 2026, to consider FY26 results and dividend
Jeena Sikho Lifecare Limited will hold its 9th Annual General Meeting on September 28, 2026. The agenda includes adopting the FY26 financial results and declaring a final dividend of ₹4.50 per equity share. The meeting will also consider reappointments and new appointments to the board of directors.
Read the summary - Medium impact
Jeena Sikho Lifecare Launches New Ayurvedic Products on September 2, 2026
Jeena Sikho Lifecare is launching six new Ayurvedic healthcare products, including Narie Xpert and Porush Xpert ranges in granule, syrup, and tablet forms. The products are for the domestic market and will be launched on September 2, 2026.
Read the summary - Low impact
Jeena Sikho Lifecare Approves FY26 Annual Report, Sets AGM for Sep 28, Dividend Record Date Sep 21
Jeena Sikho Lifecare's Board approved the FY26 Annual Report and fixed the 9th AGM for September 28, 2026. The dividend record date is set for September 21, 2026, with a final dividend of ₹4.50 per equity share recommended. Mr. Vivek Rawal appointed as AGM Scrutinizer.
Read the summary - Medium impact
JSLL Board Approves FY26 Annual Report, Sets AGM on Sep 28, Dividend Record Date Sep 21
Jeena Sikho Lifecare Limited's Board approved the FY26 Annual Report. The 9th AGM is scheduled for September 28, 2026. The record date for a final dividend of ₹4.50 per equity share is September 21, 2026. Book closure is from September 22-28, 2026.
Read the summary - Low impact
Jeena Sikho Lifecare Board Approves FY26 Annual Report, Sets AGM for Sep 28
Jeena Sikho Lifecare's Board approved the FY26 Annual Report and set the 9th AGM for September 28, 2026. A final dividend of ₹4.50 per share was recommended, with September 21, 2026, fixed as the Record Date. Book closure is from September 22-28, 2026. Mr. Vivek Rawal appointed as Scrutinizer.
Read the summary - Low impact
Jeena Sikho Lifecare to attend Twelfth Edition of Ashwamedh -Elara India Dialogue 2026
Jeena Sikho Lifecare Limited will attend the Twelfth Edition of Ashwamedh -Elara India Dialogue 2026. The investor meet is scheduled for 03rd September 2026 at Grand Hyatt, Santacruz, Mumbai. Discussions will be based on publicly available information.
Read the summary - Medium impact
Jeena Sikho Lifecare Launches 9 New Ayurvedic Healthcare Products
Jeena Sikho Lifecare Limited launched nine new Ayurvedic healthcare and wellness products on 26 August 2026. The new additions include a Headache Relief Patch and eight 500 Ml Arishta formulations, all catering to the domestic market. This expansion diversifies the company's product portfolio in the wellness sector.
Read the summary - Low impact
Jeena Sikho Lifecare to Attend GIA Healthcare Day on Aug 31
Jeena Sikho Lifecare Limited will participate in the GIA Healthcare Day on August 31, 2026. Management will meet investors and analysts in a physical group meeting at Jio World Convention Centre, BKC, from 3:30 PM to 5:00 PM. No UPSI will be shared.
Read the summary - High impact
JSLL Q1 FY27 Revenue ₹224.4 Cr, Up 29% Led by Private-Pay IPD and E-commerce
Jeena Sikho Lifecare Limited reported Q1 FY27 revenue of ₹224.4 crore, up 29% YoY. Growth was driven by private-pay IPD admissions (+33%) and e-commerce medicine sales. The company is shifting towards a higher quality earnings mix, reducing reliance on government panels. Management highlighted continued scale-up and focus on profitable growth.
Read the summary - Low impact
Jeena Sikho Lifecare: Case Studies Published in Academia Journal of Medicine
Jeena Sikho Lifecare Limited announced the publication of six case studies in the Academia Journal of Medicine and Prakriti. These studies, authored by company medical professionals, focus on Ayurvedic management of various conditions. The publications demonstrate the company's commitment to Ayurvedic research and evidence-based clinical practice.
Read the summary - Low impact
Jeena Sikho Lifecare Publishes 7 Case Studies on Ayurvedic Research
Jeena Sikho Lifecare Limited has published seven case studies in "Ayushdhara" and "International Research Journal of Ayurveda & Yoga". The studies, authored by company medical professionals, focus on Ayurvedic approaches to managing various conditions including Urticaria, T2DM, Hypothyroidism, Liver Disease, and Kidney Disease.
Read the summary - Medium impact
Jeena Sikho Lifecare Q1 FY27 Earnings Call Transcript Released
Jeena Sikho Lifecare released its Q1 FY27 earnings call transcript. The company reported Q1 FY27 revenue of ₹224 crore, EBITDA of ₹92 crore, and PAT of ₹65 crore, with 41% EBITDA and 28% PAT margins. Revenue grew 29% YoY, supported by a 47% YoY growth in the product business and 13% in services. Management reiterated a long-term vision for ₹3000 crore turnover and 7000-10000 beds.
Read the summary - Low impact
JSLL Submits Audio Recording of Q1 FY27 Earnings Conference Call Held Aug 10, 2026
Jeena Sikho Lifecare Limited released the audio recording of its Q1 FY27 earnings conference call held on August 10, 2026. The call discussed the un-audited financial results for the quarter ended June 30, 2026. The recording is available on the company's website.
Read the summary - Medium impact
Jeena Sikho Lifecare Submits Investor Presentation for Q1FY27 Earnings Call
Jeena Sikho Lifecare's Q1FY27 Revenue from Operations grew 29% YoY to ₹224.40 Crore. EBITDA increased 17% YoY to ₹92.11 Crore with a 41% margin. The company submitted its investor presentation for the Earning Conference Call scheduled for August 10, 2026.
Read the summary - Low impact
Jeena Sikho Lifecare Limited Publishes Financial Results for Q1 FY27
Jeena Sikho Lifecare Limited published its unaudited standalone and consolidated financial results for the quarter ended June 30, 2026. The results were approved by the Board on August 7, 2026, and published in newspapers on August 9, 2026.
Read the summary - Medium impact
JSLL Board Approves Q1 FY27 Results; Reappoints Key Directors
Jeena Sikho Lifecare Limited approved Q1 FY27 unaudited financial results. The board re-appointed Mr. Karan Vir Bindra as Independent Director, Mrs. Bhavna Grover as Whole-time Director, and Mr. Manish Grover as Managing Director, all for five-year terms starting August 25, 2026, subject to shareholder approval.
Read the summary - Medium impact
Jeena Sikho Lifecare Approves Q1 FY27 Results; Reappoints Directors
Jeena Sikho Lifecare approved Q1 FY27 unaudited financial results. The Board re-appointed Mr. Karan Vir Bindra as Independent Director, Mrs. Bhavna Grover as Whole-time Director, and Mr. Manish Grover as Managing Director. All re-appointments are for five-year terms starting August 25, 2026, subject to shareholder approval.
Read the summary - Low impact
Jeena Sikho Lifecare Executes Wellness Centre Agreement in Manali
Jeena Sikho Lifecare Limited executed a Room Block & Services Licence Agreement with Mr. Anil Saklani for an integrated Wellness Centre in Manali, Himachal Pradesh. The agreement, approved by the board, was executed on August 5th, 2026.
Read the summary - Low impact
Jeena Sikho Lifecare Launches New Ayurvedic Product 'Amrit Dhara Drops'
Jeena Sikho Lifecare Limited launched "Amrit Dhara Drops 20 ml", a new Ayurvedic product, on August 4, 2026. This expansion aims to bolster the company's healthcare and wellness portfolio for the domestic market.
Read the summary - Low impact
Jeena Sikho Lifecare to Host Q1 FY27 Earnings Call on August 10, 2026
Jeena Sikho Lifecare Limited will host an Earnings Conference Call on August 10, 2026, at 12:00 PM IST. This call is to discuss the Unaudited Financial Results for Q1 FY26-27, ending June 30, 2026. The company's Managing Director and CFO will be present.
Read the summary - Medium impact
Jeena Sikho Lifecare Signs Room Block & Services Licence Agreement for Wellness Centre in Manali
Jeena Sikho Lifecare Limited will establish a Wellness Centre in Manali through a Room Block & Services Licence Agreement with Ajna Resorts. The company will pay a Licence Fee of ₹7.66 Crore plus taxes over eleven months. Operations are expected to commence within 60 days of the Effective Date. The expansion aims to bolster wellness infrastructure and revenue.
Read the summary - Medium impact
Jeena Sikho Lifecare inks ₹7.66 Crore Licence Agreement for Manali Wellness Centre
Jeena Sikho Lifecare Limited will establish and operate a Wellness Centre at Ajna Resorts, Manali, through a ₹7.66 Crore licence agreement. The centre will offer Ayurveda and wellness services, featuring 30 rooms and 5 treatment rooms. Operations are expected to commence within 60 days. The initiative will be financed via internal accruals.
Read the summary - Medium impact
Jeena Sikho Lifecare Launches New Ayurvedic Pain Relief Patches
Jeena Sikho Lifecare Limited has launched four new Ayurvedic pain relief products: Back Pain Relief Patch (200 cm²), Knee Pain Relief Patch (220 cm²), Pain Relief Patch (50 cm² x 30), and Pain Relief Patch Large (75 cm² x 10). The launches aim to expand the company's healthcare and wellness portfolio.
Read the summary - Medium impact
Jeena Sikho Lifecare Expands Operations with New Noida Client Support Centre
Jeena Sikho Lifecare is establishing a new 17,700 sq. ft. Client Support Centre in Noida, Uttar Pradesh. The facility will house approximately 300 executives for customer support and engagement. The expansion requires an investment of ₹2.37 Crore, funded by internal accruals, and is expected to be operational within 45-60 days.
Read the summary - Medium impact
Jeena Sikho Lifecare to open new 60+ bed hospital in Kalyani, West Bengal by Oct '26
Jeena Sikho Lifecare Limited plans to establish a new 60+ bed Ayurvedic, Naturopathy, and Panchkarma hospital in Kalyani, West Bengal. The facility, with an investment of approximately ₹1.30 Crores, is expected to commence operations by October 2026 and will be funded through internal finance.
Read the summary - Low impact
Jeena Sikho Lifecare Limited Case Studies Published in International Journal of Advanced Research
Jeena Sikho Lifecare Limited announced that its research professionals, including the Managing Director, have published case studies in the International Journal of Advanced Research. The studies focus on Ayurvedic management of kidney disorders. Links to the publications are available on the company website.
Read the summary - Medium impact
Jeena Sikho Lifecare Appoints 5 New Directors and a Company Secretary
Jeena Sikho Lifecare Limited accepted the resignation of its Company Secretary and appointed Ms. Priya Goyal as the new Company Secretary and Compliance Officer, effective July 15, 2026. The company also appointed five new directors: Mr. Ajay Sharma, Mrs. Sapna Singh, Dr. Ish Sharma, and Mr. Ankush Kaushal, effective July 15, 2026.
Read the summary - Low impact
Jeena Sikho Lifecare Receives GST Appreciation Certificates from CBIC
Jeena Sikho Lifecare Limited received GST Appreciation Certificates from the CBIC for prompt GST filings and timely payments in FY 2025-26. The recognition covers Maharashtra, Uttar Pradesh, and Haryana, underscoring the company's commitment to regulatory compliance and governance.
Read the summary - Low impact
Jeena Sikho Lifecare Sells Land & Building for ₹9.05 Crore
Jeena Sikho Lifecare Limited approved the sale of its land and building for ₹9.05 Crore. The company will lease back the premises, ensuring continuity of operations. The asset contributed 6% to revenue and 0.72% to net worth in FY26.
Read the summary - Medium impact
Jeena Sikho Lifecare Sells Land & Building for ₹9.05 Crore, Continues Operations on Lease
Jeena Sikho Lifecare Limited approved the sale of land and building for ₹9.05 crore to M/s VSB Enterprises. The company will continue operations from the premises on a lease-back basis, ensuring no business disruption. The property contributed ₹46.47 crore revenue in FY26.
Read the summary - Low impact
Jeena Sikho Lifecare to Attend GIA Flagship Conference 2026 on June 23
Jeena Sikho Lifecare Limited's management will attend the GIA Flagship Conference 2026. A group meeting is scheduled for June 23rd, 2026, in Mumbai. The company will only discuss publicly available information.
Read the summary - Medium impact
Jeena Sikho Lifecare Signs MOU for Research Institute in Chandigarh
Jeena Sikho Lifecare Limited signed an MOU for a Research Institute in Chandigarh. The agreement with Rakesh Sharma and Neerja Rakesh Sharma is for five years, starting June 15, 2026. No rent will be paid, but the company will cover operational costs. This strengthens R&D in Ayurveda and wellness.
Read the summary - Medium impact
Jeena Sikho Lifecare to open new hospital in Lucknow by August 2026
Jeena Sikho Lifecare Limited is establishing a new hospital in Lucknow, Uttar Pradesh, with an estimated commencement in August 2026. The facility will have a capacity of 160+ beds and cover approximately 1.25 lakh sq. ft. The investment required is ₹3 Crores, financed through internal funds.
Read the summary - Medium impact
Jeena Sikho Lifecare to add Day Care Clinic in Ayodhya by August 2026
Jeena Sikho Lifecare Limited plans to establish a new Day Care Clinic in Ayodhya, Uttar Pradesh, by August 2026. The estimated investment is ₹50 Lakhs, to be funded through internal resources. This expansion aims to broaden the company's healthcare network and service offerings.
Read the summary - Medium impact
Jeena Sikho Lifecare Commences New 100-Bed Hospital Operations in Mathura
Jeena Sikho Lifecare Limited commenced operations of its new 100-bed hospital, Sanskriti Ayurvedic P.G. Medical College & Hospital, in Mathura, Uttar Pradesh, on June 10, 2026. The facility spans approximately 60,000 sq. ft. and includes 8 OPDs. This expansion supports the company's growth and healthcare infrastructure strategy.
Read the summary - Medium impact
Jeena Sikho Lifecare Limited (JSLL) Receives NABH Accreditation for Bhopal Hospital
Jeena Sikho Lifecare Limited has received NABH accreditation for its hospital in Bhopal, Madhya Pradesh. The accreditation for Panchakarma services is valid until May 4, 2029. This signifies adherence to quality healthcare standards.
Read the summary - Low impact
Jeena Sikho Lifecare Releases Audio Recording of Q4 FY26 Earnings Conference Call
Jeena Sikho Lifecare Limited has released the audio recording of its Q4 FY26 earnings conference call, held on June 2, 2026. The call discussed the audited financial results for the quarter and financial year ended March 31, 2026. The recording is available on the company's website.
Read the summary - Low impact
Jeena Sikho Lifecare Submits Revised Investor Presentation for Q4FY26 & FY26 Results
Jeena Sikho Lifecare Limited submitted a revised investor presentation on June 1, 2026, for Q4FY26 and FY26 results. FY26 revenue was ₹80,135 lakhs, with EBITDA at ₹34,963 lakhs. Q4FY26 revenue increased 55% YoY to ₹21,555 lakhs, and PAT rose 79% YoY to ₹4,535 lakhs. A final dividend of ₹4.50 per share is proposed.
Read the summary - Low impact
Jeena Sikho Lifecare Limited publishes audited FY26 financial results.
Jeena Sikho Lifecare Limited announced its audited standalone and consolidated financial results for the quarter and financial year ending March 31, 2026. The Board of Directors approved these results on May 30, 2026. The details were published on June 1, 2026.
Read the summary - Medium impact
Jeena Sikho Lifecare Presents Q4FY26 Investor Presentation, Recommends Final Dividend
Jeena Sikho Lifecare's Q4FY26 investor presentation reveals Revenue from Operations of ₹215.55 crore and PAT of ₹45.35 crore. For FY26, Revenue was ₹801.35 crore with PAT of ₹222.18 crore. The company recommended a final dividend of ₹4.50 per share.
Read the summary - Medium impact
Jeena Sikho Lifecare Approves FY26 Audited Results, Recommends Final Dividend
Jeena Sikho Lifecare's Board approved FY26 audited results with an unmodified audit opinion. A final dividend of ₹4.50 per share is recommended. M/s Forvis Mazars LLP re-appointed as Internal Auditor for FY27. Standalone profit after tax for FY26 was ₹22,217.57 lacs.
Read the summary - Medium impact
Jeena Sikho Lifecare Recommends Final Dividend of ₹4.50 Per Share
Jeena Sikho Lifecare's Board approved audited financial results for FY26. A final dividend of ₹4.50 per share is recommended, pending shareholder approval at the AGM. M/s Forvis Mazars LLP was re-appointed as Internal Auditor for FY27.
Read the summary - Low impact
JSLL to Host Q4 FY26 Earnings Conference Call on June 2, 2026
Jeena Sikho Lifecare Limited will host an Earnings Conference Call on June 2, 2026, post announcement of Q4 FY26 financial results. The call is scheduled for 01:30 PM IST and will include management participation. Registration is required to attend.
Read the summary - Low impact
Jeena Sikho Lifecare Limited Announces Publication of Case Studies in Medical Journals
Jeena Sikho Lifecare Limited announced the publication of multiple case studies and reports in medical journals like IJAHR and JAIMS. These studies showcase the company's research in Ayurvedic management of various conditions including CKD, hypertension, and infertility. The publications are available on the company's website.
Read the summary - Low impact
JSLL: Promoters Declare No Encumbrance on Shares for FY26
Jeena Sikho Lifecare Limited promoters, including Manish Grover, declared no encumbrance on their shares for FY26. As of March 31, 2026, no shares held by promoters or promoter groups were pledged. This confirms adherence to SEBI takeover regulations.
Read the summary
Model portfolios
Filings are the raw material. These are what SEBI-registered experts build from them.
- Stocks
Bharat Rising
Built around India's own shifts: capex, household savings, energy and consumption.
Moderate-Aggressive25 holdings3+ yearsView portfolio - Stocks
All-Terrain
One equity portfolio instead of three: large, mid and small cap in a single book.
Moderate-Aggressive34 holdings3+ yearsView portfolio - Stocks
Core Compounders
Companies that have already been through a downturn and came out still growing.
Moderate20 holdings3+ yearsView portfolio - Stocks
Udaan
Fast-growing, less-covered companies still early in their runway.
Aggressive29 holdings5+ yearsView portfolio